DK1078054T3 - Monomer MP52/GDF-5 med knoglemorfogenetisk aktivitet og lægemiddel indeholdende samme til forebyggelse og behandling af brusk- og knoglesygdomme - Google Patents

Monomer MP52/GDF-5 med knoglemorfogenetisk aktivitet og lægemiddel indeholdende samme til forebyggelse og behandling af brusk- og knoglesygdomme

Info

Publication number
DK1078054T3
DK1078054T3 DK99917029T DK99917029T DK1078054T3 DK 1078054 T3 DK1078054 T3 DK 1078054T3 DK 99917029 T DK99917029 T DK 99917029T DK 99917029 T DK99917029 T DK 99917029T DK 1078054 T3 DK1078054 T3 DK 1078054T3
Authority
DK
Denmark
Prior art keywords
cartilage
bone
monomers
gdf
monomer
Prior art date
Application number
DK99917029T
Other languages
Danish (da)
English (en)
Inventor
Shinji Kawai
Yoshifumi Muraki
Michio Kimura
Mieko Katsuura
Original Assignee
Bioph Biotech Entw Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioph Biotech Entw Pharm Gmbh filed Critical Bioph Biotech Entw Pharm Gmbh
Application granted granted Critical
Publication of DK1078054T3 publication Critical patent/DK1078054T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
DK99917029T 1998-05-22 1999-05-14 Monomer MP52/GDF-5 med knoglemorfogenetisk aktivitet og lægemiddel indeholdende samme til forebyggelse og behandling af brusk- og knoglesygdomme DK1078054T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10141379A JPH11335398A (ja) 1998-05-22 1998-05-22 新規な骨誘導活性を有する単量体蛋白質およびそれらからなる軟骨・骨疾患の予防および治療薬
PCT/IB1999/000866 WO1999061611A1 (fr) 1998-05-22 1999-05-14 Proteine monomere possedant une activite de morphogenese osseuse et medicament contenant ladite proteine, utile pour la prophylaxie et le traitement des maladies du cartilage et de l'os

Publications (1)

Publication Number Publication Date
DK1078054T3 true DK1078054T3 (da) 2007-03-12

Family

ID=15290635

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99917029T DK1078054T3 (da) 1998-05-22 1999-05-14 Monomer MP52/GDF-5 med knoglemorfogenetisk aktivitet og lægemiddel indeholdende samme til forebyggelse og behandling af brusk- og knoglesygdomme

Country Status (11)

Country Link
US (2) US7235241B2 (fr)
EP (1) EP1078054B1 (fr)
JP (2) JPH11335398A (fr)
AT (1) ATE346151T1 (fr)
AU (1) AU3530999A (fr)
CY (1) CY1105933T1 (fr)
DE (1) DE69934110T8 (fr)
DK (1) DK1078054T3 (fr)
ES (1) ES2272063T3 (fr)
PT (1) PT1078054E (fr)
WO (1) WO1999061611A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586388B2 (en) 1988-04-08 2003-07-01 Stryker Corporation Method of using recombinant osteogenic protein to repair bone or cartilage defects
EP1074620A1 (fr) * 1999-08-06 2001-02-07 HyGene AG Protéine monomère de la famille TGF-beta
JPH11335398A (ja) * 1998-05-22 1999-12-07 Hoechst Marion Roussel Kk 新規な骨誘導活性を有する単量体蛋白質およびそれらからなる軟骨・骨疾患の予防および治療薬
JP2002306163A (ja) * 2001-04-11 2002-10-22 Chemo Sero Therapeut Res Inst 大腸菌を宿主とする遺伝子組換えヒトトロンビンの調製方法
FI116827B (fi) 2001-08-24 2006-03-15 Univ Zuerich Luun morfogeneettisen proteiinin deleetiomutantti, sitä sisältävä farmaseuttinen koostumus ja sen käyttö
CA2562833A1 (fr) * 2004-04-27 2005-11-03 Galapagos N.V. Procedes, agents, et analyses de criblage de composes permettant d'induire une differenciation de cellules mammaliennes non differenciees en osteoblastes
ATE553123T1 (de) 2005-11-18 2012-04-15 Bioph Biotech Entw Pharm Gmbh Wachstumsfaktormutanten mit hoher aktivität
KR20080113368A (ko) * 2006-02-28 2008-12-30 상뜨로 나쇼날 드 라 러쉐르쉐 샹띠피크 네트린-1 활성을 이용한 항암 화합물의 스크리닝
GB0604966D0 (en) * 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
SI2121142T1 (sl) * 2007-01-25 2012-12-31 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Uporaba GDF-5 za izboljšanje ali vzdrževanje videza kože
EP2019117A1 (fr) * 2007-07-27 2009-01-28 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Procédé de purification optimisé de la protéine recombinante du facteur de croissance
CA2806143A1 (fr) 2010-07-30 2012-02-02 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mb H Dispositifs d'administration de medicaments et formulations de facteur de croissance pour accelerer la cicatrisation de plaies
CN102382187B (zh) * 2011-05-03 2013-05-22 中国人民解放军军事医学科学院放射与辐射医学研究所 Fbxl15蛋白片段及其编码基因和应用
EP2537538A1 (fr) 2011-06-22 2012-12-26 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH Pansement biorésorbable
EP2602264A1 (fr) 2011-12-05 2013-06-12 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH Mutant de GDF-5 pour induire la formation de cartilage
US11464888B2 (en) 2017-06-12 2022-10-11 Warsaw Orthopedic, Inc. Moldable formulations containing an oxysterol in an acellular tissue matrix
JP2023507007A (ja) 2019-12-18 2023-02-20 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 疼痛及び軟骨破壊を治療するためのｇｄｆ－５変異体の使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158934A (en) * 1989-09-01 1992-10-27 Genentech, Inc. Method of inducing bone growth using TGF-β
US5208219A (en) * 1991-02-14 1993-05-04 Celtrix Pharmaceuticals Inc. Method for inducing bone growth
US5118667A (en) * 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
ATE319823T1 (de) * 1993-12-07 2006-03-15 Inst Genetics Llc Bmp-12, bmp-13 und diese enthaltende sehne- induzierende zusammensetzungen
JPH0931098A (ja) * 1995-07-24 1997-02-04 Hoechst Japan Ltd 新規なタンパク質ｈｍｗヒトｍｐ５２
JPH11335398A (ja) * 1998-05-22 1999-12-07 Hoechst Marion Roussel Kk 新規な骨誘導活性を有する単量体蛋白質およびそれらからなる軟骨・骨疾患の予防および治療薬

Also Published As

Publication number Publication date
DE69934110T8 (de) 2007-06-06
EP1078054A1 (fr) 2001-02-28
ES2272063T3 (es) 2007-04-16
US7235241B2 (en) 2007-06-26
JP4272357B2 (ja) 2009-06-03
DE69934110D1 (de) 2007-01-04
JP2002516098A (ja) 2002-06-04
CY1105933T1 (el) 2011-04-06
WO1999061611A1 (fr) 1999-12-02
AU3530999A (en) 1999-12-13
JPH11335398A (ja) 1999-12-07
DE69934110T2 (de) 2007-03-01
US7638129B2 (en) 2009-12-29
ATE346151T1 (de) 2006-12-15
US20060019886A1 (en) 2006-01-26
EP1078054B1 (fr) 2006-11-22
US20080318856A1 (en) 2008-12-25
PT1078054E (pt) 2007-02-28

Similar Documents

Publication Publication Date Title
DK1078054T3 (da) Monomer MP52/GDF-5 med knoglemorfogenetisk aktivitet og lægemiddel indeholdende samme til forebyggelse og behandling af brusk- og knoglesygdomme
AU2002305450A1 (en) Proteomimetic compounds and methods
BR0107613A (pt) Bloqueio do crescimento de axÈnios mediado por receptor nogo
DE69729125D1 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
BR0312421A (pt) Uso de inibidores de cept e opcionalmente inibidores hmg coa redutase e/ou agentes anti-hipertensivos
ITPD920071A1 (it) Impiego di preparazioni di acido ialuronico per la formazione di tessuto osseo
JP2005046155A (ja) Ｂｍｐ−１１組成物
DE60219793D1 (de) Methode zur behandlung von zytokinvermittelten erkrankungen
ATE323510T1 (de) Gentherapeutische verfahren zur bereitstellung von apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dyslipidämischer erkrankungen
ATE114169T1 (de) Morphogenetisches knochenprotein.
PT808898E (pt) Reagente e metodo para inibicao da expressao de n-ras
BR9917005A (pt) Combinação de inibidores de fbpase e sensibilizadores de insulina para o tratamento de diabete
ATE264913T1 (de) Protease-resistente analoge des thrombomodulin
KR930702995A (ko) 세포증식 매트릭스 및 그 용도
DE60024997D1 (de) Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen
DE69630974D1 (de) Hyaluronsäurerezeptoren bindende stoffe und deren verwendung zur behandlung von tumoren und restenose
DK82892D0 (da) Anvendelse af braadgifte fra bier og hvepse til fremstilling af laegemidler til behandling af infektioner
FR2773079B1 (fr) Cible de traitement de l'atherosclerose, de l'obesite et du diabete de type ii
HUP0300787A2 (hu) Új interferon a sclerosis multiplex kezelésére
DE69630948T2 (de) Peptide und medikamente für knochenkrankheiten welche diese peptide als aktive bestandteile beinhalten
DE69928814D1 (de) Verwendung von tgf-beta inhibitoren zur behandlung von cerebralen krankheiten
EP2300610A1 (fr) Nouvelles protéines apparentées à bmp-12 et procédés pour les préparer
Akiyama et al. Cloning of a novel gene specifically expressed in clonal mouse chondroprogenitor-like EC cells, ATDC5